Cancer Antigen 27-29

Overview

  • EPIC Code:
  • IMO422
  • Soft Test Code:
  • C2729
  • Send Out Test Code:
  • 29493
Alternate Names
  • CA 27-29
  • CA 27.29
Clinical Significance

CA 27.29 may be useful for monitoring patients for metastatic breast cancer.


Specimen Collection & Preparation

Specimen Requirements

1.0 mL Serum in a SST Gold Top Tube


Alternate Specimen

1.0 mL Serum from a Red Top Tube in a Plastic Vial


TransportAndStorage

7 days Ambient (transport)
7 days Refrigerated
28 days Frozen

24 hours unspun


Collection Instructions

 


Minimum Volume

0.5 mL


Neonatal Volumne

Clinical Interpretation

Reference Range:

<38 U/mL


Test Comments:

This test was performed using the Siemens Chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. CA 27.29 levels, regardless of value, should not be interpreted as absolute evidence of the presence or absence of disease.


Methodology:
  • Immunoassay (IA)

Clinical Significance

CA 27.29 may be useful for monitoring patients for metastatic breast cancer.


Documentation

CA 27.29 is not intended as a screening test.


Production Schedule

Sites Performed
  • Quest - Chantilly
Days Performed
Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
Departments
  • Sendouts - Clinical
Turn Around Time

2 to 3 days


Coding & Compliance

CDM

01429457


CPT Coding

86300


Medical Necessity May Apply